
biote Corp.
biote Corp.(BTMD)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
btmd · 股价预测 · 7 位分析师(近3月)· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$4.00
Consensus
$3.25
+38.9% upside
Low
$2.50
Median: $3.25 · Last Close: $2.34
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$3.25
38.9% upside
High Target
$4
70.9%
Low Target
$2.5
6.8%
Current Price
$2.34
as of today
Based on analyst price targets, the BTMD stock price prediction for the next 12 months ranges from $2.5 to $4. The consensus BTMD price forecast of $3.25 implies 38.9% upside from the current price of $2.34.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.46 | ↑ 5.00% |
1-day model range: $2.44–$2.47. Peak: $2.47 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -31.4% |
| 2028 | $1 | -42.2% |
| 2029 | $1 | -46.7% |
| 2030 | $1 | -48.8% |
| 2031 | — | -49.8% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BTMD · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-16 | Truist Securities | Maintains | Buy→Buy |
| 2026-03-12 | B. Riley Securities | Maintains | Neutral→Neutral |
| 2026-03-12 | TD Cowen | Maintains | Buy→Buy |
| 2025-08-07 | B. Riley Securities | Downgrade ↓ | Buy→Neutral |
| 2025-03-13 | Craig-Hallum | Maintains | Buy→Buy |
| 2024-03-13 | Roth MKM | Maintains | Buy→Buy |
| 2024-01-18 | Roth MKM | Maintains | Buy→Buy |
| 2024-01-18 | Truist Securities | Maintains | Buy→Buy |
| 2023-08-15 | TD Cowen | Maintains | Outperform→Outperform |
| 2023-08-14 | Roth MKM | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on biote Corp. (BTMD) stock. Of the recent 14 rating actions, 0 were upgrades and 1 were downgrades. 7 analysts currently cover BTMD.
分析师推荐趋势
BTMD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$191M
↓ 11.7% YoY
Revenue Next Year
$204M
↑ 6.7% YoY
EPS This Year
$0.28
EPS Next Year
$0.36
↑ 28.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast BTMD EPS of $0.28 for the current fiscal year, based on estimates from 1 analysts. The BTMD revenue forecast is $191M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BTMD 股价预测由两类独立数据源支撑:来自 7 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。BTMD 的共识目标价为 $3.25(+38.9% 上行空间),分析师共识为 Buy。
BTMD 的短期预测(明日)为 $2.46(+5.00%)。 BTMD 对 2027 年的股价预测均值为 $2。 BTMD 对 2030 年的预测区间为 $1–$1。
biote Corp. 在 NASDAQ 上市,代码 BTMD。BTMD 在 2027 年的整体展望偏积极,在覆盖分析师中约 86% 对应 Buy 共识。
常见问题
BTMD 预测 · 8 个问题根据 7 位华尔街分析师,BTMD 的 12 个月平均目标价为 $3.25,最高 $4.00、最低 $2.50。若有图表,中位目标价可在上方查看。相对当前价 $2.34,隐含约 +38.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.